citrulline has been researched along with Respiratory Distress Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bellani, G; Curley, G; Dos Santos, C; Horie, S; Laffey, JG; McAuley, D; McNicholas, B; Nichol, A; O'Kane, C; Pham, T; Rezoagli, E; Rocco, PRM | 1 |
Cynober, L | 1 |
Mittal, N; Sanyal, SN | 1 |
Bernard, GR; Christman, BW; Cunningham, G; Magarik, JA; Rice, TW; Summar, ML; Ware, LB; Wheeler, AP; Wickersham, N | 1 |
1 trial(s) available for citrulline and Respiratory Distress Syndrome
Article | Year |
---|---|
Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis.
Topics: Adult; Aged; Biomarkers; Citrulline; Female; Humans; Male; Middle Aged; Respiratory Distress Syndrome; Sepsis | 2013 |
3 other study(ies) available for citrulline and Respiratory Distress Syndrome
Article | Year |
---|---|
Emerging pharmacological therapies for ARDS: COVID-19 and beyond.
Topics: Antioxidants; Ascorbic Acid; Citrulline; COVID-19 Drug Treatment; Drug Therapy; Glycoproteins; Humans; Mesenchymal Stem Cells; Pandemics; Peptides, Cyclic; Pyridones; Pyrimidines; Receptors, Tumor Necrosis Factor, Type I; Respiratory Distress Syndrome; Steroids; Trypsin Inhibitors | 2020 |
Citrulline: just a biomarker or a conditionally essential amino acid and a pharmaconutrient in critically ill patients?
Topics: Citrulline; Female; Humans; Male; Respiratory Distress Syndrome; Sepsis | 2013 |
Surfactant blocks lipopolysaccharide signaling by inhibiting both NFκB and PARP activation in experimental ARDS.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Alveolar Epithelial Cells; Animals; Bronchoalveolar Lavage Fluid; Citrulline; Drug Combinations; Enzyme Activation; Fatty Alcohols; Hydrogen-Ion Concentration; I-kappa B Kinase; Lipopolysaccharides; Lung; Male; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Polyethylene Glycols; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Swine | 2011 |